Venous Thromboembolism Risk Rise Reported in Individuals With Extra Sex Chromosomes
Researchers saw a significant uptick in VTE risk in individuals with supernumerary sex chromosome aneuploidies in both the Geisinger MyCode and UK Biobank cohorts.
Akonni Bio Obtains FDA 510(k) Clearance for TruDiagnosis MDx System, PGx Test
Akonni has received clearance for a molecular diagnostic instrument and a saliva-based pharmacogenomics test for warfarin metabolism.
Genotyping Appears to Offer Warfarin Dosing Edge in New Clinical Trial
Results from a randomized clinical trial known as GIFT suggest that genotype-guided warfarin dosing is linked to fewer adverse events than clinical dosing.
U of Chicago Researchers Discover Novel Polymorphisms Associated With VTE in African Americans
The research team found three novel polymorphisms on chromosome 20 associated with an increased risk of blood clots in populations of African descent.
Meta-Analysis Implicates Two New Loci in Venous Thromboembolism
Data from a dozen GWAS led researchers to venous thromboembolism-associated variants in the TSPAN15 and SLC44A2 genes.